Skip to search formSkip to main contentSkip to account menu

antihemophilic factor (recombinant) pegylated 1 UNT Injection

Known as: ANTIHEMOPHILIC FACTOR,RECOMB,PEGYLATED 1000UNIT/VIL INJ, ANTIHEMO FACT PEGYLATED 1000UNIT/VI INJ, ANTIHEMO FACT PEGYLATED 2000UNIT/VI INJ 
National Institutes of Health

Related topics

Related topics

12 relations
Antihemophilic Factor, Human RecombinantBlood Coagulation FactorDrug AllergyEnzyme Activators [MoA]

Broader (1)

BLOOD DERIVATIVES

Narrower (1)

antihemophilic factor (recombinant) pegylated 1 UNT Injection [Adynovate]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Mattilsynet vil følge opp risikovurdering om akrylamid
2015
2015
Abstract A97: Control of PDAC tumor progression by RNA interference targeting indoleamine 2,3-dioxygenase using salmonella as a delivery vehicle facilitated by PEGPH20
The dismal prognosis of late stage, unresectable pancreatic adenocarcinoma (PDAC) patients has prompted the search for novel… 
2014
2014
Fabrication of PEGylated fibrinogen: a versatile injectable hydrogel biomaterial.
Hydrogels are one of the most versatile biomaterials in use for tissue engineering and regenerative medicine. They are assembled… 
2013
2013
Abstract 3375: Phase 1 pharmacodyamic activity of multiple-dose PEGylated hyaluronidase PH20 (PEGPH20) in patients with solid tumors.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Enzymatic degradation of hyaluronan (HA), a key… 
2013
2013
Pharmacokinetic (PK)/pharmacodynamic (PD) results from a phase Ib study of pegylated hyaluronidase PH20 (PEGPH20) in combination with gemcitabine (Gem) in patients with pancreatic cancer.
e15005 Background: Enzymatic degradation of hyaluronan (HA) is a novel strategy to target the desmoplastic stroma of pancreatic… 
2012
2012
Abstract 2672: Phase 1 pharmacokinetics (PK) & pharmacodynamics (PD) of PEGylated hyaluronidase PH20 (PEGPH20) in patients with solid tumors
Enzymatic degradation of hyaluronan (HA), a key component of the extracellular matrix (ECM), can enhance tumor perfusion, improve… 
2010
2010
Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
2010
2010
Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice.
Insulin resistance, a condition in which insulin action is impaired, is one of the characteristic features of type 2 diabetes… 
2008
2008
Effects of Pegylated Hamster Red Blood Cells on Microcirculation
The objective of this study was to examine the effects of polyethylene glycol (PEG) treated red blood cells (RBCs) on the… 
2007
2007
Functionalized gold nanorods for molecular optoacoustic imaging
The development of gold nanoparticles for molecular optoacoustic imaging is a very promising area of research and development… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)